Bacil Pharma Q2 Results

  • BSE: 524516
  • NSE: -
  • ISIN: INE711D01018
  • Sector: Biotechnology & Drugs
BSE
45.170.87 (1.96%)
Volume7.30 K
Updated: Tue 26 Nov, 2024 | 15:15:00
NSE
This stock is not traded on NSE
Today: 43.42
45.18
52-Wk: 4.68
50.02

Q2 Results Highlights

  • Total Income
    ₹0.00 Cr.
    -
  • Operating Profit
    ₹-0.07 Cr.
    (63.09%)
  • Profit After Tax
    ₹0.48 Cr.
    (NA%)
  • Operating Margin
    NA%
    (NA%)
Note: Comparison is on YoY basis

Quarterly - Bacil Pharma Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 24QoQ CompSep 23YoY Comp
Total Revenue 0.000.00-%0.00-%
Selling/ General/ Admin Expenses Total 0.040.02-%0.02-%
Depreciation/ Amortization 0.000.00-%0.00-%
Other Operating Expenses Total 0.030.02-%0.02-%
Total Operating Expense 0.070.04-%0.04-%
Operating Income -0.07-0.04-%-0.04-%
Net Income Before Taxes 0.49-0.03-%-0.01-%
Net Income 0.48-0.03-%-0.01-%
Diluted Normalized EPS 0.82-0.06-%-0.02-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts